IQI
LLY icon

Integrated Quantitative Investments’s Eli Lilly LLY Stock Holding History

Integrated Quantitative Investments’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$936K Sell
780
-2,607
-77% -$2.66M 0.15% 232
2026
Q1 		$3.12M Buy
3,387
+2,313
+215% +$2.34M 0.57% 26
2025
Q4 		$1.15M Buy
+1,074
New +$1.03M 0.25% 166

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Integrated Quantitative Investments's LLY Position: Q2 2026 in Review

Integrated Quantitative Investments reduced its Eli Lilly (LLY) stake by 77% in Q2 2026, selling an estimated $2.66M and leaving 780 shares worth $936K. The position accounts for 0.15% of the portfolio, ranked #232.

Integrated Quantitative Investments first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.12M in Q1 2026. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Integrated Quantitative Investments held 780 shares of Eli Lilly worth $936K as of Q2 2026.
  • Integrated Quantitative Investments sold 2,607 Eli Lilly shares in Q2 2026, an estimated $2.66M.
  • Eli Lilly made up 0.15% of Integrated Quantitative Investments's portfolio in Q2 2026, its #232 holding.
  • Integrated Quantitative Investments first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Integrated Quantitative Investments's Eli Lilly position peaked at $3.12M in Q1 2026.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.